Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 5OTHER_GOV 2NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Esophageal Neoplasms 3Breast Neoplasms 3Recurrence 2Fallopian Tube Neoplasms 2Uterine Cervical Neoplasms 1Unresectable Non-small Cell Lung Cancer 1Thyroid Neoplasms 1Stomach Neoplasms 1Sexual Dysfunction, Physiological 1Radiation Injuries 1Prostatic Neoplasms 1Pilonidal Sinus 1Pain, Postoperative 1Pain 1Ovarian Neoplasms 1Neoplasm Metastasis 1Mouth Neoplasms 1Melanoma 1Lung Neoplasms 1Intestinal Diseases 1Head and Neck Neoplasms 1Endometrial Neoplasms 1Death 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1Adenocarcinoma 1

Interventions

taxane 2Surgical Procedures, Operative 2Poly(ADP-ribose) Polymerase Inhibitors 2Neoadjuvant Therapy 2Carboplatin 2Bevacizumab 2olaparib 1niraparib 1cediranib 1Platinum 1Paclitaxel 1Maintenance 1Etoposide 1Drug Therapy 1Diagnostic Imaging 1CP protocol 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Fallopian Tube Neoplasms × Surgical Procedures, Operative × Clear all
NCT06602063 2025-06-27

Surgery for Relapsed Ovarian Cancer in Precision

Shanghai Gynecologic Oncology Group

Phase 1/2 Not yet recruiting
33 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT03983226 2022-03-18

Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial)

Shanghai Gynecologic Oncology Group

Phase 2 Recruiting
167 enrolled
Gynecologic

Fallopian Tube Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡